Leerink Partnrs Has Bearish Outlook for Revvity Q2 Earnings

Revvity, Inc. (NYSE:RVTY) – Leerink Partnrs cut their Q2 2025 earnings per share estimates for shares of Revvity in a research note issued to investors on Monday, April 28th. Leerink Partnrs analyst P. Souda now expects that the company will post earnings of $1.14 per share for the quarter, down from their previous forecast of $1.22. The consensus estimate for Revvity’s current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity’s Q3 2025 earnings at $1.25 EPS, Q1 2026 earnings at $1.15 EPS and Q3 2026 earnings at $1.39 EPS.

RVTY has been the topic of several other reports. The Goldman Sachs Group cut their target price on shares of Revvity from $140.00 to $125.00 and set a “buy” rating on the stock in a research report on Tuesday. KeyCorp lifted their price objective on shares of Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Barclays lowered their price objective on shares of Revvity from $140.00 to $110.00 and set an “overweight” rating on the stock in a report on Thursday, April 10th. Robert W. Baird dropped their price target on shares of Revvity from $127.00 to $125.00 and set an “outperform” rating on the stock in a research report on Tuesday. Finally, Sanford C. Bernstein lowered shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price objective for the company. in a research note on Friday, January 10th. Four equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $126.46.

Revvity Price Performance

RVTY stock opened at $94.75 on Wednesday. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. Revvity has a 12 month low of $88.53 and a 12 month high of $129.50. The firm has a market cap of $11.38 billion, a P/E ratio of 42.87, a P/E/G ratio of 3.82 and a beta of 1.07. The company’s 50-day moving average price is $104.08 and its two-hundred day moving average price is $112.67.

Revvity (NYSE:RVTY) last issued its earnings results on Monday, April 28th. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.96 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The company had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. During the same period in the previous year, the company posted $0.98 EPS. The firm’s revenue for the quarter was up 2.3% compared to the same quarter last year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Shareholders of record on Friday, July 18th will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date is Friday, July 18th. Revvity’s payout ratio is 12.67%.

Insider Activity

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the transaction, the insider now owns 33,400 shares in the company, valued at $4,232,782. The trade was a 31.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.68% of the company’s stock.

Institutional Trading of Revvity

A number of hedge funds have recently added to or reduced their stakes in RVTY. Drake & Associates LLC lifted its stake in shares of Revvity by 31.7% during the first quarter. Drake & Associates LLC now owns 14,997 shares of the company’s stock worth $1,587,000 after buying an additional 3,611 shares during the period. Timber Creek Capital Management LLC grew its stake in Revvity by 20.2% during the 1st quarter. Timber Creek Capital Management LLC now owns 40,177 shares of the company’s stock valued at $4,251,000 after acquiring an additional 6,760 shares in the last quarter. IFM Investors Pty Ltd increased its stake in Revvity by 6.1% during the first quarter. IFM Investors Pty Ltd now owns 25,959 shares of the company’s stock worth $2,746,000 after acquiring an additional 1,484 shares during the last quarter. Teacher Retirement System of Texas acquired a new stake in Revvity during the first quarter worth $1,884,000. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in shares of Revvity by 2.4% in the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,458 shares of the company’s stock valued at $1,424,000 after buying an additional 310 shares in the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.